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Neutrophil gelatinase-associated lipocalin (Ngal, 24p3, SIP24,
lipocalin 2, or siderocalin) was originally purified from
neutrophils, but with unknown function. Recently, it was
identified that Ngal activates nephron formation in the
embryonic kidney, is rapidly and massively induced in renal
failure and possesses kidney-protective activity. We would
like to propose that blood, urine, and kidney Ngal levels are
the real-time indicators of active kidney damage, rather than
one of many markers of functional nephron number (as
Forest Fire Theory). Ngal is a novel iron-carrier protein
exerting pleiotropic actions including the upregulation of
epithelial marker E-cadherin expression, opening an exciting
field in cell biology.
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MOLECULAR STRUCTURE OF NGAL
Neutrophil gelatinase-associated lipocalin (Ngal) belongs to
the lipocalin superfamily, which are secreted or cytosolic
proteins with barrel-like structure, carrying hydrophobic
ligands (such as fatty acids, retinoids, and pheromones) in
their core pocket.1 Recent works have elucidated the patho-
physiological roles of lipocalins in energy homeostasis.
Retinol-binding protein 4 impairs insulin signaling in muscles
causing insulin resistance,2 whereas lipocalin-type (or brain)
prostaglandin D synthase (b-trace) inhibits insulin-
stimulated proliferation of vascular smooth muscle cells
resulting in protection against atherosclerosis.3 Mice with a
null mutation in adipocyte fatty acid-binding protein 4 or
adipocyte protein 2 become obese under high-fat diet but
do not develop insulin resistance.4 Little is known about the
involvement of the ligands in these metabolic activities of
lipocalins. Goetz et al.5 carried out an epoch work of the
X-ray crystallography for recombinant human Ngal protein
expressed in Escherichia coli. They demonstrated that the
ligand for Ngal is siderophore. Siderophores are a diverse
group of small (1 kDa or less) non-peptide iron (Fe3þ )-
binding chemicals produced in bacteria, fungi, and plants
and their mammalian version remains to be identified.6–9 Of
note, XL1-Blue strain of E. coli synthesizes a siderophore
called enterochelin (or enterobactin), but BL21 commonly
used for recombinant protein expression does not make
enterochelin.5 Probably outside the pocket, Ngal binds
with gelatinase B (matrix metalloproteinase-9 or type IV
collagenase) and with hepatocyte growth factor and
modulates their activity.10–12
NGAL IN KIDNEY DEVELOPMENT
Mammalian metanephric mesenchyme and ureteric bud
coordinate a complicated interaction to develop themselves
into mature nephrons.13 Barasch et al.14 established an organ
culture system, where isolated rat metanephric mesenchyme
converts into glomeruli and proximal tubules by stimulation
with condition media prepared from a mouse ureteric
bud cell line. Leukemia-inhibitory factor and Ngal were the
epithelial inducers purified at the protein level using this
assay.14,15 Genetic inactivation of Ngal (by Flo et al.) or
leukemia-inhibitory factor signal transducer gp130 does not
result in agenesis of the kidney, indicating a high redundancy
in nephrogenesis pathways.14,16 Yang et al.15 have shown that
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mouse Ngal protein secreted from cultured ureteric bud cells
possesses nephron-inducing activity and can also bind iron.
Surprisingly, Ngal–bacterial siderophore–iron complex has
much stronger activity than Ngal–siderophore (without iron)
and apo-Ngal (without siderophore),17 indicating the first
example of ‘siderophore-binding proteins,’ in any species,
dependent on the presence of iron for the biological activity.7
NGAL IN RENAL FAILURE
Recapture of genetic program of embryo is often observed in
tissue injuries. Devarajan et al.18,19 have analyzed animal
models of acute renal failure to screen biomarkers useful in
the clinical settings and to understand the molecular
mechanisms of kidney injury, to begin with by use of
microarray. Within a few hours, Ngal mRNA is highly
upregulated after kidney injury, such as renal ischemia-
reperfusion and cisplatin nephropathy, where Ngal induction
precedes the elevation of classical markers for kidney
damage: serum creatinine, urinary N-acetyl glucosaminidase,
b 2-microglobulin levels.19,20 Furthermore, Mori et al.9 and
other groups have reported that Ngal protein is abundantly
accumulated in the blood, urine, and renal proximal and
distal tubules in acute renal failure of humans: in cases
associated with renal ischemia (sepsis, hypovolemia, and
heart failure), nephrotoxin (antibiotics, cisplatin, bispho-
sphonate, nonsteroidal anti-inflammatory drugs, radio-
contrast, and hemoglobinuria), kidney-parenchymal damage
(glomerulonephrits, minimal change disease, focal segmental
glomerulosclerosis, and diabetic nephropathy), hemolytic-
uremic syndrome and posttransplant rejection. Mishra
et al.21 presented the clinical usefulness of blood and urinary
Ngal as extremely early markers of acute kidney disease. As
early as 1–2 h after the cardiopulmonary bypass surgery in
children and in adults (with average bypass time of 2–3 h),
the Ngal levels are dramatically and specifically elevated in
those who are going to develop acute renal failure (diagnosed
by more than 50% rise in the serum creatinine levels a few
days later).21,22 Acute worsening of chronic renal failure may
be also predicted by elevated urinary Ngal levels (Nickolas T
et al., submitted). In general, to evaluate the severity of renal
failure, at least two aspects should be considered (Figure 1):
the ratio of functional versus atrophic nephrons (or the
results of kidney injury) and the severity of on-going damage.
Analogy may hold true for forest fire (Forest Fire Theory).
We propose here that induction of Ngal expression is a real-
time indicator of active renal injury.
Functional significance of Ngal upregulation in renal
failure was investigated by Mori9 and Mishra et al.,23 who
analyzed separate sets of animals. Single intraperitoneal or
subcutaneous injection of recombinant Ngal protein into
mice (Figure 2) significantly ameliorates kidney damage
after renal ischemia-reperfusion injury, if Ngal is given
before ischemia or 1 h after reperfusion. Berger et al.24
generated Ngal knockouts and found no difference in renal
damage at 24 h after renal ischemia-reperfusion compared
with wild-type mice. Although Ngal mRNA upregulation is a
rapid response, the speed and amount of endogenous Ngal
induction may not be sufficient to show significant protec-
tion in this setting. Experiments in more chronic and milder
models may give different results.
TRANSCRIPTIONAL REGULATION OF NGAL
Neutrophils,25 monocytes/macrophages,26 and adipocytes27
are cells with abundant Ngal expression (Figure 3).
Importantly, immature neutrophils (myelocytes and meta-
myelocytes) have high expression level of Ngal mRNA,
whereas mature neutrophils/granulocytes in the circulation
have lost the mRNA but contain large amount of Ngal
protein,25 making it impossible to determine the involvement
of neutrophil-derived Ngal in tissue injury by in situ
mRNA hybridization. Ngal expression is highly induced
not only in kidney injury, but also in epithelial inflammation
of intestine,28 skin and airway,29 and in bacterial infection16
and cancer.30 Ngal inducers so far identified in vitro are
(a) (b)
Figure 1 | Forest Fire Theory for worsening renal function. Forest
(kidney) is composed of trees (nephrons). Both models (a) and (b)
have 60% viable trees (shown in green) and 40% of trees are burnt
down (shown in gray, corresponding to sclerosis of glomeruli, and
atrophy of tubules). However, model (a) has much stronger fire
(shown in red, that is ongoing nephron damage) than model (b). We
propose that serum creatinine level or glomerular filtration rate is a
marker for functional nephron numbers (green trees), whereas serum,
urinary, or renal Ngal level indicates the extent of active lesion in the
kidney (red fire in the forest).
G
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Figure 2 | Kidney protection by a red protein. Ngal protein shows a
red color when ligated with iron and siderophore (left). Intravenous
injection of A568-labeled Ngal (red fluorescence, right) into normal
mice results in rapid glomerular (G) filtration and reabsorption by
proximal tubules. Administration of iron-loaded Ngal protects the
kidney from renal ischemia-reperfusion injury.
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IL-1b, tissue necrosis factor a, lipopolysaccharide, basic
fibroblast growth factor, prostaglandin F2 a, phorbol ester,
dexamethasone, retinoic acid, serum, and hypoxia.20,26,29,31
BIOLOGICAL ACTIVITY OF NGAL
Ngal exerts a broad range of biological activities (Figure 3).
The coexistence of siderophore and iron is required not only
for mesenchymal–epithelial transition of embryonic kidney17
and oncogene Ras-transformed epithelial cells by Hanai
et al.,30 but also for kidney protection from renal failure by
Mori et al.9 In contrast, Ngal–siderophore complex without
iron17 (and potentially apo-Ngal)32 can chelate iron from
cells and iron deprivation is the mechanism for apoptosis of
pro-B cells,32,33 and for inhibition of bacterial growth and
erythropoiesis.5,16,34 Various other activities of Ngal are
increasingly reported.12,28
Induction of mesenchymal–epithelial transition by Ngal is
associated with upregulation of epithelial marker E-cadherin
expression, but this is a slow process. In metanephric
mesenchyme, morphologically distinct epithelia is observed
only 7–10 days after addition of Ngal–siderophore–iron
complex (unpublished observation).15 By contrast, epithelia
induced by leukemia-inhibitory factor can be observed
within 4–5 days.13,14 In Ras-transformed mammary cells,
E-cadherin protein accumulation was evaluated 48 h after
treatment with the complex.30 Hanai et al.30 demonstrated
that treatment with Ngal–siderophore–iron suppresses Raf,
mitogen-activated protein kinase (MEK)-1/2, extracellular
signal-regulated kinase (ERK)-1/2 pathway of mitogen-
activated protein kinase and inhibits E-cadherin phosphor-
ylation, causing decrease in E-cadherin degradation. Not only
treatment with Ngal–siderophore–iron complex but also
transfection with cDNA and infection with adenovirus
encoding Ngal results in mesenchymal–epithelial transition
of transformed cells, implying that fetal calf serum or cells
themselves provide mammalian siderophores. In the case
of renal ischemia-reperfusion injury, phosphorylation of
MEK1/2 and ERK1/2 is biphasic (transient activation within
30 min, followed by long-term activation for several days)
and the levels of their phosphorylation are not necessarily
parallel with the severity of renal injury,35 suggesting that
suppression of this pathway is not the major mechanism for
Ngal-mediated kidney protection. Administration of Ngal
is ineffective if given 2 h after reperfusion,9 implying that
Ngal is preventing the early injuries (in part by upregulating
a protective enzyme heme oxygenase-1)9 rather than
stimulating the recovery process.
In healthy adult kidneys, Ngal36 and other lipocalins
(whose sizes are 17–43 kDa) including retinol-binding
protein 4, a1-microglobulin37 and probably also liver-type
fatty acid-binding protein 1 and prostaglandin D synthase are
freely filtrated in the glomeruli, bound to multiligand
scavenger-receptor megalin (expressed abundantly and spe-
cifically on the brush borders of proximal tubules) and taken
up efficiently by endocytosis (as well as albumin and
b2-microglobulin).38 Insufficient tubular reabsorption (ow-
ing to specific saturation in the endocytic pathway or general
malfunctioning of proximal tubules) should contribute in
part to urinary Ngal. Devireddy et al.32 identified brain-type
organic cation transporter as Ngal receptor in pro-B cells.
Iron-free siderophore-like activity (which assists the
binding of Ngal and Fe3þ ) is detectable in the normal urine
of humans, mice, rats, and dogs.9,39 Tear lipocalin, a major
protein component specifically found in human tears, also
binds with siderophores.40 Lipocalin 12, found specifically in
mouse epididymis, is also structurally related to Ngal and
may have binding capacity for siderophores.41
CHARACTERISTICS OF NGAL AS RENAL FAILURE BIOMARKER
Ngal induction is a rapid event detectable within a few hours,
characterizing Ngal as one of immediate early genes or acute-
phase reactants such as IL-6 and C-reactive protein.
Fold induction of Ngal mRNA and protein is log order of
magnitude, reaching 1000-fold in most severe cases of renal
injury.9,39 Therefore, normalization for urinary creatinine
level is not necessary to evaluate urinary Ngal.21 Indeed, a
patient with urinary Ngal level of 40 mg/ml died of multi-
organ failure 12 h after urine collection9 (Mori K et al.,
unpublished observation).
DIRECTIONS FOR FUTURE RESEARCH
There are a number of siderohpre-dependent and -indepen-
dent activities reported for Ngal. The role of endo-
genously expressed Ngal in these activities should be better
verified using Ngal-deficient mice. During renal ischemia-
reperfusion injury, the liver also starts to express Ngal
mRNA.39 Therefore, the source of Ngal protein in the blood
and urine during renal injury can be a complex from the
kidney, liver, and white blood cells (in the injured tissues
and in circulation). Tissue-specific disruption of Ngal
gene will make it possible to investigate what is the pre-
dominant source of Ngal, as a biomarker or as a protective
mechanism for renal failure. Purification and identification
of mammalian siderophores and to learn their meta-
bolism and regulation are also important steps. The reported
method to recognize siderophores is only available for
iron-free molecules.9 A new way to detect iron-loaded
siderophores must be invented. Characterization of Ngal
receptors, their downstream intracellular signaling, and
subcellular localization of events will help elucidate the
Abundant expression
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Figure 3 | Summary of expressional regulation and biological
activities of Ngal.
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detailed molecular mechanism underlying the actions of
Ngal, siderophores, and iron.
CONCLUSION
Ngal is a very unique protein endowed with iron-carrying
activity and diagnostic and therapeutic utilities for renal
failure, which is acquiring an explosion of attention by
researchers and clinicians beyond nephrology.
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